Pure Global AI
NCT06401564Recruiting

Virtual Reality Based Rehabilitation After Ischemic Stroke

Improving Functional and Cognitive Outcomes After Ischemic Stroke Using Virtual Reality Based Rehabilitation
Stony Brook UniversityClinicalTrials.govdeviceDevice trial
Study focus
Disease/Condition
Ischemic Stroke
Drug/Device/Intervention
Virtual Reality Therapy
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Stony Brook University
Location
Stony Brook, United States of America
Timeline & enrollment
Phase
N/A
Start date
Apr 17, 2023
End date
Dec 01, 2026
Enrollment
15 participants
Primary outcome

Feasibility survey,Simulator sickness questionnaire

Summary

Use the template below as a guide to write a brief study description in plain language.
 Tailor the text that appears in brackets and yellow to your research study. To finalize,
 delete the text in italics.
 
 The goal of this single-arm study is to explore the use of early virtual reality-based
 rehabilitation as an adjunct to conventional physical/occupational therapy in adult patients
 with acute ischemic stroke. The main question it aims to answer is:
 
 Feasibility and tolerability of using immersive Virtual Reality technology-based therapy for
 patients suffering from acute ischemic stroke in an inpatient hospital setting Participants
 will receive 1 or 2 virtual reality therapy sessions and complete surveys at the end of each
 session.

ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionCerebral infarction, unspecifiedOther cerebral infarction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06401564
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06401564 through Pure Global AI's free database. This phase not specified trial is sponsored by Stony Brook University and is currently Recruiting. The study focuses on Ischemic Stroke. Target enrollment is 15 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.